Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Changzhou Qianhong Biopharma Co Ltd
Operating Income
Changzhou Qianhong Biopharma Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
|
Operating Income
¥193.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥4.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
12%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Operating Income
-¥749.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Changzhou Qianhong Biopharma Co Ltd's Operating Income?
Operating Income
193.7m
CNY
Based on the financial report for Mar 31, 2024, Changzhou Qianhong Biopharma Co Ltd's Operating Income amounts to 193.7m CNY.
What is Changzhou Qianhong Biopharma Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
3%
Over the last year, the Operating Income growth was -36%.